Differential expression of immunohistochemical markers in bladder smooth muscle and myofibroblasts, and the potential utility of desmin, smoothelin, and vimentin in staging of bladder carcinoma

Jemal, 2008, Cancer statistics, 2008, CA Cancer J Clin, 58, 71, 10.3322/CA.2007.0010 Eble, 2004 Cheng, 2000, Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens, Am J Clin Pathol, 113, 275, 10.1309/94B6-8VFB-MN9J-1NF5 Chang, 2001, Correlation between biopsy and radical cystectomy in assessing grade and depth of invasion in bladder urothelial carcinoma, Urology, 57, 1063, 10.1016/S0090-4295(01)00998-0 Lopez-Beltran, 2003, Stage pT1 bladder carcinoma: diagnostic criteria, pitfalls and prognostic significance, Pathology, 35, 484, 10.1080/00313020310001619127 Ro, 1987, Muscularis mucosa of urinary bladder. Importance for staging and treatment, Am J Surg Pathol, 11, 668, 10.1097/00000478-198709000-00002 Paner, 2007, Further characterization of the muscle layers and lamina propria of the urinary bladder by systematic histologic mapping: implications for pathologic staging of invasive urothelial carcinoma, Am J Surg Pathol, 31, 1420, 10.1097/PAS.0b013e3180588283 Vakar-Lopez, 2007, Muscularis mucosae of the urinary bladder revisited with emphasis on its hyperplastic patterns: a study of a large series of cystectomy specimens, Ann Diagn Pathol, 11, 395, 10.1016/j.anndiagpath.2006.12.014 Aydin, 2002, Vascular plexus is a differentation criterion for muscularis mucosa from muscularis propria in small biopsies and transurethral resection materials of urinary bladder?, Int Urol Nephrol, 34, 315, 10.1023/A:1024493518202 Humphrey, 2004, Urinary bladder pathology 2004: an update, Ann Diagn Pathol, 8, 380, 10.1053/j.anndiagpath.2004.08.012 Epstein, 2004 Young, 1988, Transitional cell carcinoma of the urinary bladder with pseudosarcomatous stroma, Am J Clin Pathol, 90, 216, 10.1093/ajcp/90.2.216 McKenney, 2005, The role of immunohistochemistry in the diagnosis of urinary bladder neoplasms, Semin Diagn Pathol, 22, 69, 10.1053/j.semdp.2005.11.005 Abdou, 2007, CD10 expression in tumour and stromal cells of bladder carcinoma: an association with bilharziasis, APMIS, 115, 1206, 10.1111/j.1600-0643.2007.00645.x Bircan, 2006, CD10 expression in urothelial bladder carcinomas: a pilot study, Urol Int, 77, 107, 10.1159/000093901 Iwaya, 2002, Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome, Virchows Arch, 440, 589, 10.1007/s00428-002-0639-4 Ogawa, 2002, Expression of CD10 by stromal cells during colorectal tumor development, Hum Pathol, 33, 806, 10.1053/hupa.2002.125773 van der Loop, 1996, Smoothelin, a novel cytoskeletal protein specific for smooth muscle cells, J Cell Biol, 134, 401, 10.1083/jcb.134.2.401 Kuijpers, 2007, Cadherin-11 is expressed in detrusor smooth muscle cells and myofibroblasts of normal human bladder, Eur Urol, 52, 1213, 10.1016/j.eururo.2007.01.052 Maake, 2006, Expression of smoothelin in the normal and the overactive human bladder, J Urol, 175, 1152, 10.1016/S0022-5347(05)00315-0 Lapetino, 2008, Diagnostic utility of antibody to smoothelin in the distinction of muscularis mucosa from muscularis propria of the urinary bladder (abstract), Mod Pathol, 21, 165A Amin, 2003, Updated protocol for the examination of specimens from patients with carcinoma of the urinary bladder, ureter, and renal pelvis, Arch Pathol Lab Med, 127, 1263, 10.5858/2003-127-1263-UPFTEO Greene, 2002 Philip, 2000, Intravesical adipose tissue: a quantitative study of its presence and location with implications for therapy and prognosis, Am J Surg Pathol, 24, 1286, 10.1097/00000478-200009000-00013 Skalli, 1989, Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filament proteins, Lab Invest, 60, 275 Jones, 1990, Alpha-smooth muscle actin as a marker for soft tissue tumours: a comparison with desmin, J Pathol, 162, 29, 10.1002/path.1711620107 Eyden, 2008, The myofibroblast: phenotypic characterization as a prerequisite to understanding its functions in translational medicine, J Cell Mol Med, 12, 22, 10.1111/j.1582-4934.2007.00213.x Ceballos, 2000, Is anti-h-caldesmon useful for distinguishing smooth muscle and myofibroblastic tumors? An immunohistochemical study, Am J Clin Pathol, 114, 746, 10.1309/K5JP-A9EN-UWN7-B5GG Eyden B, Banerjee SS, Shenjere P, et al. The myofibroblast and its tumours: a review. J Clin Pathol; published online: 17 October 2008 [e-pub ahead of print]. Ratajska, 2001, Differentiation of the smooth muscle cell phenotypes during embryonic development of coronary vessels in the rat, Histochem Cell Biol, 116, 79, 10.1007/s004180100306 Johansson, 1999, Smoothelin in adult and developing human arteries and myocardium, Histochem Cell Biol, 112, 291, 10.1007/s004180050450 van der Loop, 1997, Differentiation of smooth muscle cells in human blood vessels as defined by smoothelin, a novel marker for the contractile phenotype, Arterioscler Thromb Vasc Biol, 17, 665, 10.1161/01.ATV.17.4.665